Simplex Trading, LLC Finch Therapeutics Group, Inc. Transaction History

Simplex Trading, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 27, 2023	SELL	$0.34 - $0.56 $136 - $224	-400 Reduced 46.46%	461 $0
Q4 2022 Feb 02, 2023	SELL	$0.36 - $1.26 $242 - $849	-674 Reduced 43.91%	861 $0
Q3 2022 Nov 04, 2022	SELL	$1.75 - $2.88 $252 - $414	-144 Reduced 8.58%	1,535 $2,000
Q2 2022 Aug 03, 2022	BUY	$1.91 - $5.11 $3,206 - $8,579	1,679 New	1,679 $4,000

Ticker FNCH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,688,400
Market Cap $63.4M
Description
Finch Therapeutics Group, Inc., a clinical-stage microbiome therapeutics company, develops a novel class of orally administered biological drugs in the United States. The company's lead candidate is CP101, an orally administered microbiome capsule that is in Phase 3 clinical trial for the treatment of patients with recurrent Clostridioides diffi...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.